# Chinese Stocks
Latest news and articles about Chinese Stocks
Total: 6 articles found
Regulators Tighten Noose on Juli Sling Amid Surging Volatility and Plummeting Profits
Chinese industrial giant Juli Sling is under CSRC investigation for misleading information disclosures following a period of extreme stock volatility. Despite reporting revenue growth in early 2026, the company's profits have plummeted by 38%, signaling deep-seated internal or operational issues.
China’s AI Chip Champion Cambricon Reclaims Market Throne Amid 700 Billion Yuan Valuation Surge
Cambricon Technologies saw its stock price surge over 12% to reach a record high, pushing its market cap past 700 billion yuan. The company has reclaimed its leadership position in China's AI chip sector, driven by intense demand for domestic computing power solutions.
China’s Tech-Heavy ChiNext Retreats After Testing Decade-Highs Amid Profit-Taking
China's ChiNext index hit its highest level since the 2015 bubble before reversing sharply to close down over 1%. Despite a massive 2.42 trillion yuan turnover, the market saw widespread declines, though pharmaceutical and AI-leasing stocks bucked the downward trend.
A Psychological Breakthrough: China’s Markets Reclaim 4,000 as AI and Green Energy Fuel New Momentum
China's Shanghai Composite Index reclaimed the 4,000-point mark amid a massive 2.38 trillion RMB surge in trading volume. The rally was primarily driven by the computing hardware and lithium battery sectors, reflecting investor confidence in China's industrial tech policy.
ChiNext Surges to Four-Year High as Lithium and AI Sectors Ignite Growth Rally
China's ChiNext Index hit a post-2021 high on Friday, driven by a 3.78% jump led by the lithium battery and AI hardware sectors. High trading volumes and new regulatory reforms from the CSRC suggest a shift in investor sentiment toward high-growth, technology-driven sectors.
A Billion-Yuan Gamble: The High Stakes of Weidi Shares' Desperate Diversification
Weidi Shares is launching a 1.1 billion RMB cash acquisition of a 'Little Giant' precision manufacturer to pivot away from its failing core business. The deal, funded largely by debt and featuring extreme valuation premiums, has triggered internal board dissent and warnings of a potential financial crisis.